← JOURNAL / LEIMAN LAB
FIELD NOTE 002AI & TECHNOLOGYRESEARCH / BIOTECH & DEFENCE

Warhound: The $200 Million Plan to Engineer Military Working Dogs

Warhound's plans for genetically modified service dogs raise practical questions about genetics, training, cost and animal welfare. The public evidence is still limited.

Editorial illustration for Warhound and Military Biotech
LEIMAN LAB / 002   ·   EDITORIAL ILLUSTRATION

Palmer Luckey, founder of Anduril, and Ben Lamm, CEO of Colossal Biosciences, announced a new company called Warhound. It raised $200 million for military working-dog cloning, genetic modification and protective equipment. No genetically enhanced working dogs have yet been publicly presented.

How Warhound plans to make them

According to Ben Lamm, the team has already collected cell samples from military working dogs for planned cloning. The first genetic interventions would target the risk of inherited diseases.

The team has also discussed changing working capabilities, including scent detection. These remain proposals: the company has not published validated evidence of enhanced olfactory performance in military working dogs.

What is Anduril doing here?

Anduril is expected to supply protective vests, goggles, hearing protection, sensors and software connecting a dog to its handler. The announced technology is external equipment. The company has not announced implanting devices inside the animals.

Why change the existing system?

Warhound claims that more than 80% of US military working dogs are sourced from Europe and that fewer than half make it into service after screening and training. The company wants a more predictable supply of animals with higher training completion rates.

What this will cost remains unknown. There is no public price for a trained dog, no evidence yet that the approach works, and no long-term health data on clones produced by the programme.

What is worth watching

Cloning copies a genome, not a training history. Working performance also depends on environment, conditioning and the relationship with a handler. Genetically similar animals can still perform differently.

Testing the effects of genetic interventions would require controlled comparisons: animals trained under comparable programmes and followed for health outcomes. Warhound has not published that evidence.

The company promises lifetime care for the animals, including after service. Evaluating that promise will require future data on injuries, health and lifespan. Those data do not yet exist.

SOURCES4 LINKS
  1. Warhound — official updated press release (23 October 2026) ↗COMPANY CLAIMS
  2. WIRED — on genetically modified military dogs ↗INDEPENDENT REPORTING
  3. Financial Times — Palmer Luckey unveils military dog startup ↗INDEPENDENT REPORTING
  4. TechCrunch — Warhound raises $200M to engineer war dogs (22 October) ↗INDEPENDENT REPORTING

Research snapshot: 25 October 2026. Announced investments and intentions are not evidence that planned animal interventions are effective or safe.

COMMENTS / 0

SELECT TEXT TO DISCUSS A PASSAGE